106
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of visual pathways using visual evoked potentials in the patients with impaired fasting glucose and impaired glucose tolerance

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 22-29 | Received 14 Nov 2017, Accepted 25 Jun 2018, Published online: 30 Oct 2018

References

  • Tabák AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279–2290.
  • American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(Suppl 1):S14–S80.
  • Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–824.
  • Gayathri V, Vijayalakshmi B, Chandrasekhar M. Electrophysiological assessment of neuropathy in visual pathway of diabetes mellitus. J Diabetol. 2012;1(4):1–7.
  • Parisi V, Uccioli L, Monticone G, et al. Electrophysiological assessment of visual function in IDDM patients. Electroencephalogr Clin Neurophysiol. 1997;104:171–179.
  • Karlica D, Galetovic D, İvanisevic M, et al. Visual evoked potential can be used to detect a prediabetic form of diabetic retinopathy in patients with diabetes mellitus type I. Coll Antropol. 2010;34(2):525–529.
  • Jain AK. Neuro Electrodiagnostic techniques. In: Jain AK, editor. Manual of practical physiology for MBBS. New Delhi: Arya Publication; 2003. p. 261–264.
  • Ponte F, Anastasi M, Lauricella M, et al. Optic pathway conduction in insulin-dependent diabetics. Doc Ophthalmol. 1986;63:313–319.
  • Algan M, Ziegler O, Gehin P, et al. Visual evoked potentials in diabetic patients. Diabetes Care. 1989;12:227–229.
  • Odom J.V, Bach M, Barber C, et al. Visual evoked potentials standard. Doc Ophthalmol. 2004;108(2):115–123.
  • Odom JY, Bach M, Brigell M, et al. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016;133:1–9.
  • Carter JL. Visual evoked potentials. In: Daube JR, Rubin DI, editors. Clinical Neurophysiology. New York: Oxford University Press; 2009. p. 311–322.
  • Talebi M, Meshkinghalam A, Andalib S. Association between visual evoked potential and disease severity, disease duration and visual hallucination in patients with idiopathic parkinsonism. Novelty Biomed. 2014;2(4):120–125.
  • Azar SA, Talebi M, Taheraghdam A. Comparison of visual evoked potentials in patients undergoing peritoneal dialysis and hemodialysis and its association with blood biochemical profile. J Exp Clin Neurosci. 2014;1(1):26–30.
  • Satman I. Diabetes Mellitus Tanı ve İzleminde Yeni Kriterler ve Belirlenme Gerekçeleri. Türkiye Klinikleri J Int Med Sci. 2007;3(3):1–15.
  • Kumbasar AB. Bozulmus Glikoz T, Glikozu BA. In: Altuntas Y, Yenigün M, editors. Her Yönüyle Diabetes Mellitus. 2.baskı. İstanbul, Turkey: Nobel Tıp Kitabevleri; 2001. p. 236–245.
  • Leibowitz HM, Krueger DE, Maunder LR, et al. The framingham eye study monograph: an ophthalmolgical and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration and visual acuity in general population of adults. Surv Ophthalmol. 1980;24:335–610.
  • Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy XIV. Ten years incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;12:1217–1228.
  • Tas A, Bayraktar M.Z, Uzeyir E, et al. Prevalence and risk factors for diabetic retinopathy in Turkey. Gulhane Med J. 2005;47(3):164–174.
  • Argyropoulou MI, Zikou AK, Tzovara I, et al. Non-arteritic anterior ischemic optic neuropathy: evaluation of the brain and optic pathway by conventional MRI and magnetization transfer imaging. Eur Radiol. 2007;17:1669–1674.
  • Aminoff MJ. Electrodiagnosis in Clinical Neurology. Doc Ophthalmol. 2004;108:115–123.
  • Celesia GG, Peachey NS. Visual evoked potentials and electroretinograms. In: Niedermayer E, Lopes da Silva F, editors. Electroencephalography: basic principles, clinical applications, and related fields. Vol. 99. 4th ed. Baltimore: Williams & Wilkins; 1999. p. 968–993.
  • Odom J.V, Bach M, Brigell M, et al. ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol. 2010;120:111–119.
  • Imam M, Shehata OH. Subclinical central neuropathy in Type-2diabetes mellitus. Bull Alex Fac Med. 2009;45(1):65–73.
  • Rodarte C, Hood DC, Yang EB, et al. The effects of glaucoma on the latency of the multifocal visual evoked potential. Br J Ophthalmol. 2006;90(9):1132–1136.
  • Collier A, Reid N, Mc Innes A, et al. Somatosensory and visual evoked potentials in insulin dependent diabetics with mild peripheral neuropathy. Diabetes Res Clin Pract. 1988;5:171–175.
  • Cirillo D, Gonfiantini E, De Grandis D, et al. Visual evoked potentials in diabetic children and adolescents. Diabetes Care. 1984;7:273–275.
  • Khardori R, Soller NG, Good DC, et al. Brainstem auditory and visual evoked potentials in type 1 (insulin-dependent) patients. Diabetologia. 1986;29:362–365.
  • Kumar R, Sundararajan D, Ponraj R. S, et al. A study on early detection of changes in vısual pathway due to diabetes mellitus by visual evoked potential. Int J Med Res Health Sci. 2013;3(1):161–164.
  • Heravian J, Ehyaei A, Nasser S, et al. Pattern visual evoked potentials in patients with type II diabetes mellitus J Ophthalmic Vis Res. 2012;7(3):225–230.
  • Collier A, Mitchell JD, Clarke BF. Visual evoked potential and contrast sensitivity function in diabetic retinopathy. Br Med J. 1985;27:248.
  • Uccioli L, Parisi V, Monticone G, et al. Electrophysiological assessment of visual function in newly-diagnosed IDDM patients. Diabetologia. 1995;38:804–808.
  • Parisi V, Uccioli L, Parisi L, et al. Neural conduction in visual pathways in newly-diagnosed IDDM patients. Electroencephalogr Clin Neurophysiol. 1998;108:490–496.
  • Papakostopoulos D, Hart JC, Corrall RJ, et al. The scotopic electroretinogram to blue flashes and pattern reversal visual evoked potentials in insulin dependent diabetes. Int J Psychophysiol. 1996;21:33–43.
  • Balta O, Sungur G, Yakin M, et al. Pattern visual evoked potential changes in diabetic patients without retinopathy. J Ophthalmol. 2017;14:1–7.
  • S. Gupta, G. Gupta, V. K. Deshp. Visual evoked potential changes in patients with diabetes mellitus without retinopathy. Int J Res Med Sci. 2015;3(12):3591–3598.
  • Kumar Hari KV, Ahmad FM, Sood S, et al. Visual evoked potential to assess retinopathy in gestational diabetes mellitus. Can J Diabetes. 40(2);2016:131–134.
  • Oken BS, Chiappa KH, Gill E. Normal temporal variability of the P100. Electroencephalogr Clin Neurophysiol. 1987;68(2):153–156.
  • Martinelli V, Piatti PM, Filippi M, et al. Effects of hyperglycaemia on visual evoked potentials in insülin dependent diabetic patients: Acta Diabetol. 1993;29:23–37.
  • Charng J, Nguyen C.T, Zheng He, et al. Conscious Wireless electroretinogram and visual evoked potentials in rats. PLoS One. 2013;8(9):e74172. doi:10.1371/journal.pone.0074172
  • Amy T. Waldman, Grant T, et al. Optical coherence tomography and visual evoked potentials in pediatric MS. Neurol Neuroimmunol Neuroinflamm. 2017;4(4):e356.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.